Mispregnol (Misoprostol)

Misoprostol, the active ingredient in Mispregnol, is a prostaglandin analog presented as an oral tablet for oral use. It is employed to prevent NSAID‑induced gastric ulcers and to manage obstetric conditions such as medical abortion, induction of labor, and postpartum hemorrhage.

GNH USA supplies Mispregnol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is distributed to health‑care providers across multiple regions. Its manufacturing follows Good Manufacturing Practice (GMP) and each batch undergoes rigorous testing for purity and potency.

Misoprostol acts on prostaglandin pathways to provide gastroprotective and uterotonic effects.

- NSAID‑induced gastric ulcer prevention: reduces gastric acid secretion and enhances mucosal protection, lowering ulcer incidence. - Medical abortion: induces uterine contractions and cervical softening to terminate early pregnancy. - Induction of labor: promotes cervical ripening and stimulates uterine activity to facilitate delivery. - Management of postpartum hemorrhage: contracts uterine muscle to reduce bleeding after childbirth.

Misoprostol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Abdominal pain: cramping or discomfort in the stomach area. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects: - Uterine hyperstimulation: excessively strong or frequent contractions. - Anaphylaxis: life‑threatening allergic reaction with rash, swelling, and breathing difficulty. - Severe postpartum hemorrhage: uncontrolled bleeding despite treatment.

When using Misoprostol, several precautions should be observed to minimize risks.

- Assess renal function: dose adjustment may be needed in impaired kidneys. - Evaluate NSAID use: concurrent NSAIDs can diminish gastroprotective benefit. - Monitor uterine activity: careful observation required in pregnant patients to avoid excessive contractions. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution with cardiovascular disease: prostaglandin effects may affect blood pressure. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Misoprostol interacts with several medicines; awareness of these interactions helps ensure safe therapy.

Major Interactions (Avoid): - Concomitant uterotonic agents: may cause excessive uterine contraction. - High‑dose NSAIDs: can reduce Misoprostol’s gastroprotective efficacy. - Anticoagulants: increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive effect. - Corticosteroids: combined use may increase gastrointestinal irritation. - Macrolide antibiotics: may alter Misoprostol metabolism.